NovaBay Pharmaceuticals, Inc.

NBY
$1.16 (+ $0.04 + 3.57%)
Last updated: 2026-06-10 21:26 UTC
NBY Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINN/A
Market Price1.16
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E Ratio0.89
EPS5.36
Market Cap$598.6M
Book Value-0.45
Price to Book-10.65
Beta0.48
52w High6.47
52w Low0.46
Next Earnings DateN/A

NovaBay Pharmaceuticals, Inc. trades under ticker NBY on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure.

About the Company
NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Price History